By the Top Tier Newswire AI Desk · July 29, 2026 at 8:29 AM ET · reviewed against 21 wire stories
HUMANA INC (HUM) is drawing unusual attention today. Our newswire has captured 21 stories on HUM across 12 sources in the last 36 hours, with AI sentiment reading mixed (avg 56/100).
Humana (HUM) shares are moving lower today, down more than 7% in early trading, despite reporting second-quarter earnings and revenue that beat estimates. The stock opened with a significant gap down from the prior close and has traded in a narrow range since. The primary driver of the decline appears to be the company’s decision to reaffirm its full-year adjusted earnings outlook, a move that contrasted with expectations of a more optimistic revision and left some investors underwhelmed.
What Happened
Humana reported second-quarter 2026 adjusted earnings per share of $7.61, exceeding the $7.22 estimate, and revenue of $40.888 billion, beating the $40.611 billion forecast. The company also highlighted continued growth in its Medicare Advantage business. However, it maintained its full-year adjusted earnings outlook, a decision that appears to have disappointed some market participants. Unlike some of its peers, which have raised full-year guidance following strong quarterly results, Humana’s unchanged forecast may have led to a sell-off as investors recalibrated expectations. The company also announced the expansion of its board of directors, adding Paul Smith and Frederick Crawford, signaling a strategic focus on technology and financial discipline.
What The Data Shows
The intraday session began with a -7.4% gap down from the prior close of $388.71, opening at $359.80. The stock briefly touched its session high of $388.71 at 7:55 AM ET before retreating to a low of $355.00. The last trade was at $364.89 with no volume reported so far. The stock has traded within a 52-week range of $163.11 to $428.88 and has a trailing twelve-month revenue growth of 14.1%. With a P/E ratio of 41.5 and a beta of 0.72, the stock is seen as relatively stable but expensive. Recent insider and congressional activity includes multiple small purchases by members of Congress, with the most recent filing on July 21, 2026.
What To Watch
The stock is currently trading in a narrow range with no unusual options activity or short interest data provided. Investors should monitor the company’s full-year performance and any further updates on its Medicare Advantage strategy. No earnings date is provided, but coverage breadth remains at 13 stories from 10 sources in the last 36 hours.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
Evercore ISI upgrades Humana stock rating on Stars recovery outlook
Evercore ISI upgrades Humana stock rating on Stars recovery outlook
12h agoSeeking AlphaBULLISH 56Earnings
Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Track
Humana Inc. aims for a 3% pre-tax margin by 2028 via Medicare Advantage quality and cost cuts. Click for this HUM earnings update.
13h agoSeeking AlphaBULLISH 63Analyst
Humana upgraded to outperform at Evercore on growth prospects
Evercore ISI upgrades Humana to outperform on Medicare growth and 4-star ratings upside potential. Read more here.
15h agoWSJ BusinessBEARISH 42Earnings
Humana Maintains Adjusted Earnings Outlook, Underwhelming Investors
The unchanged guidance came as the health insurer’s second-quarter results broadly beat Wall Street expectations. Shares fell.
18h agoSeeking AlphaBULLISH 56General
Humana targets 3% pretax margin in 2028 while planning 2027 MA exits impacting ~600,000 members
Humana (HUM) Q2 2026 earnings call highlights: Medicare Advantage 2027 bid strategy, Stars risk, cost trends, and plan exits.
18h agoSeeking AlphaNEUTRAL 50Earnings
Humana Inc. (HUM) Q2 2026 Earnings Call Transcript
Humana Inc. (HUM) Q2 2026 Earnings Call July 29, 2026 8:00 AM EDTCompany ParticipantsLisa Stoner - Vice President of Investor RelationsJames Rechtin -...
18h agoYahoo FinanceNEUTRAL 54Earnings
S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings
19h agoCNBC BusinessBULLISH 63Earnings
Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line
Humana maintained its 2026 adjusted profit outlook of at least $9 per share, which some analysts called a "disappointment" amid high expectations for insurers.
20h agoSeeking AlphaNEUTRAL 50General
4 stocks to watch on Wednesday: STX, VRT, HUM, SOFI
Stock futures slip ahead of the Fed decision. Watch STX, SOFI, VRT and HUM as earnings move prices—see key results, guidance and analyst notes.
20h agoSeeking AlphaBEARISH 42Earnings
Humana drops despite Q2 beat on unchanged outlook
Humana (HUM) stock drops despite strong Q2 2026 earnings and revenue as the company, unlike its peers, reaffirms its full-year outlook. Read more here.
Frequently asked questions
Why is HUM stock moving today?
HUMANA INC (HUM) is drawing unusual attention today. Our newswire has captured 21 stories on HUM across 12 sources in the last 36 hours, with AI sentiment reading mixed (avg 56/100). The most recent driver: "Evercore ISI upgrades Humana stock rating on Stars recovery outlook" (Investing.com Analyst Ratings).
Is HUM a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of HUM coverage reads 56/100 over 21 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →